January 30, 2008 - TopSpin Medical Inc. announced the first commercial installation of the Cathamaran Intravascular MRI System at ZOL Hospital, Genk, Belgium, with the first procedures performed on Jan. 16.
Janssen-Cilag International NV announced IONSYS (fentanyl iontophoretic transdermal system), a new needle-free system ...
February 2008 - The body regulates its core temperature by reducing the blood flow to the extremities, but anesthesia ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 29, 2008 - The Medicines Company received the European Commission�s authorization of an expanded use for ...
January 29, 2008 � A novel treatment for blood clots in the legs, in which injecting or �lacing� the clot with a ...
Power Medical Interventions Inc. said the FDA cleared its 510(k) application for marketing its intelligent iDrive ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 29, 2008 - Edwards Lifesciences Corp. received conditional approval from the FDA for the addition of the ...
NEC Electronics America Inc. introduced two new color, 21.3-inch diagonal amorphous-silicon thin-film transistor (TFT) liquid-crystal display (LCD) modules for medical imaging applications.
January 28, 2008 - A new multi-center, international clinical trial that compares the safety and effectiveness of thoracic endovascular aortic repair (TEVAR) to open surgery for descending thoracic aortic aneurysms (TAA), indicates that TEVAR (the less invasive endovascular graft) is a promising treatment option for many patients.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Spectrum Surgical Instruments Corp. has assembled 42 brushes in designing its endoscopic instrument cleaning brush kit ...
January 28, 2008 - Inverness Medical Innovations will acquire Matria Healthcare, Inc. for approximately $1.18 billion, consisting of approximately $900 million to acquire the Matria shares of common stock and assumption of approximately $280 million of Matria's indebtedness outstanding, which will further Inverness' approach of bringing its proprietary diagnostic products into the home.
BD Diagnostics said it received clearance from the FDA for the BD GeneOhm StaphSR assay, which the company says is the first test to rapidly and simultaneously identify two deadly healthcare-associated infections (HAIs) - Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus (MRSA) - from patients with positive blood cultures.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 28, 2008 - Toshiba America Medical Systems Inc. said today the FDA cleared the new open-bore 1.5T Vantage Titan ...
The FDA granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the first fibrin sealants available as an adjunct to hemostasis for use in surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.
January 28, 2008 – Medtronic Inc. has launched a clinical trial to confirm the safety and efficacy of the Medtronic ...